More on SMMT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (7.4 Score)
- Holders

Upcoming Events

- Earnings (8/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Summit Therapeutics (NQ:SMMT)
Delayed: 15.11 +0.17 (1.14%)
Prev. Close $14.94  
Open$14.73 
52 Wk High$19.75 
52 Wk Low$4.26 
Day High$15.35 
Day Low$14.60 
P/E N/A  
EPS$0.00 
Volume2,307,450 

Friends, Peers and Foes (?): 4RY, AZN, PFE, GSK, BNTX (more...)

Feb 26, 2026 06:45 PM Summit Therapeutics to Present at Upcoming Investor Conferences
Feb 25, 2026 06:38 AM Summit Therapeutics plc (SMMT) PT Lowered to $30 at H.C. Wainwright
Feb 24, 2026 05:15 AM Citi Opens Catalyst Watch on Summit Therapeutics plc (SMMT)
Feb 24, 2026 04:31 AM Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens
Feb 23, 2026 04:59 PM Form S-8 Summit Therapeutics Inc.
Feb 23, 2026 04:22 PM Summit Therapeutics (SMMT) Misses Q4 EPS by 21c
Feb 23, 2026 04:10 PM Form 10-K Summit Therapeutics Inc. For: Dec 31
Feb 23, 2026 04:08 PM Form 8-K Summit Therapeutics Inc. For: Feb 23
Feb 23, 2026 04:05 PM Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025
Feb 17, 2026 05:05 PM Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026
View All Articles

Entities mentioned with SMMT

View All Entities